Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression - PubMed (original) (raw)
Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression
Levi J Beverly et al. Cancer Res. 2005.
Abstract
Aberrant Notch signaling contributes to more than half of all human T-cell leukemias, and accumulating evidence indicates Notch involvement in other human neoplasms. We developed a tetracycline-inducible mouse model (Top-Notch(ic)) to examine the genetic interactions underlying the development of Notch-induced neoplastic disease. Using this model, we show that Notch suppresses p53 in lymphomagenesis through repression of the ARF-mdm2-p53 tumor surveillance network. Attenuation of Notch expression resulted in a dramatic increase in p53 levels that led to tumor regression by an apoptotic program. This shows that continued Notch activity is required to maintain the disease state. However, all tumors relapsed with rapid kinetics, most of which, by reactivation of Notch expression. Furthermore, by directly inhibiting the mdm2-p53 interaction by using either ionizing radiation or the novel small molecule therapeutic Nutlin, p53 can be activated and cause tumor cell death, even in the presence of sustained Notch activity. Therefore, it is the suppression of p53 that provides the Achilles heel for Notch-induced tumors, as activation of p53 in the presence of Notch signaling drives tumor regression. Our study provides proof-of-principle for the rational targeting of therapeutics against the mdm2-p53 pathway in Notch-induced neoplasms. Furthermore, we propose that suppression of p53 by Notch is a key mechanism underlying the initiation of T-cell lymphoma.
Similar articles
- Efficient p53 activation and apoptosis by simultaneous disruption of binding to MDM2 and MDMX.
Hu B, Gilkes DM, Chen J. Hu B, et al. Cancer Res. 2007 Sep 15;67(18):8810-7. doi: 10.1158/0008-5472.CAN-07-1140. Cancer Res. 2007. PMID: 17875722 - Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
Meng X, Carlson NR, Dong J, Zhang Y. Meng X, et al. Oncogene. 2015 Nov 12;34(46):5709-17. doi: 10.1038/onc.2015.39. Epub 2015 Mar 30. Oncogene. 2015. PMID: 25823025 Free PMC article. - Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
Eischen CM, Roussel MF, Korsmeyer SJ, Cleveland JL. Eischen CM, et al. Mol Cell Biol. 2001 Nov;21(22):7653-62. doi: 10.1128/MCB.21.22.7653-7662.2001. Mol Cell Biol. 2001. PMID: 11604501 Free PMC article. - Inhibition of the p53-MDM2 interaction: targeting a protein-protein interface.
Chène P. Chène P. Mol Cancer Res. 2004 Jan;2(1):20-8. Mol Cancer Res. 2004. PMID: 14757842 Review. - Control of p53 ubiquitination and nuclear export by MDM2 and ARF.
Zhang Y, Xiong Y. Zhang Y, et al. Cell Growth Differ. 2001 Apr;12(4):175-86. Cell Growth Differ. 2001. PMID: 11331246 Review.
Cited by
- Proteomics and Bioinformatics Identify Drug-Resistant-Related Genes with Prognostic Potential in Cholangiocarcinoma.
Kerdkumthong K, Roytrakul S, Songsurin K, Pratummanee K, Runsaeng P, Obchoei S. Kerdkumthong K, et al. Biomolecules. 2024 Aug 8;14(8):969. doi: 10.3390/biom14080969. Biomolecules. 2024. PMID: 39199357 Free PMC article. - Notch signaling, hypoxia, and cancer.
Guo M, Niu Y, Xie M, Liu X, Li X. Guo M, et al. Front Oncol. 2023 Jan 31;13:1078768. doi: 10.3389/fonc.2023.1078768. eCollection 2023. Front Oncol. 2023. PMID: 36798826 Free PMC article. Review. - Oncogenic signaling pathway mediated by Notch pathway-related genes induces immunosuppression and immunotherapy resistance in hepatocellular carcinoma.
Ma P, Zou C, Xia S. Ma P, et al. Immunogenetics. 2022 Dec;74(6):539-557. doi: 10.1007/s00251-022-01273-6. Epub 2022 Jul 27. Immunogenetics. 2022. PMID: 35895154 - Autophagy-mediated degradation of NOTCH1 intracellular domain controls the epithelial to mesenchymal transition and cancer metastasis.
Zada S, Hwang JS, Lai TH, Pham TM, Ahmed M, Elashkar O, Kim W, Kim DR. Zada S, et al. Cell Biosci. 2022 Feb 14;12(1):17. doi: 10.1186/s13578-022-00752-3. Cell Biosci. 2022. PMID: 35164848 Free PMC article. - RAS-mediated tumor stress adaptation and the targeting opportunities it presents.
Redding A, Aplin AE, Grabocka E. Redding A, et al. Dis Model Mech. 2022 Feb 1;15(2):dmm049280. doi: 10.1242/dmm.049280. Epub 2022 Feb 11. Dis Model Mech. 2022. PMID: 35147163 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous